The MarketWatch 50 - Lina Khan.
Federal Trade Commission Chair Lina Khan has been making her case against monopoly power, especially when it comes to big technology companies. So far she has been losing, failing to stop Microsoft’s takeover of Activision Blizzard and Facebook parent Meta Platform's acquisition of Within Unlimited. But Khan is just getting started. Her FTC, along with 17 states, sued Amazon alleging the company used its market position to quash competition and overcharge sellers.
Shot to prominence as a 29-year-old law student after The Yale Law Journal published her 2017 article titled “Amazon’s Antitrust Paradox.”‘My father has been lying about his finances. He owes a lot of money’: He’s not in good health. Will my mother be responsible when he dies? ‘He does own several properties, but they’re not selling given how terrible the housing market is at the moment.'One semiconductor company is expected to grow sales nearly as quickly as Nvidia through 2025The $1 trillion ‘wall of worry’ for commercial real estate that spirals through 2027
There are about $1 trillion of commercial real-estate loans coming due through the end of 2024, and closer to $2.5 trillion by the end of 2027.My mom had a trust, so why do we still need probate to settle her estate?
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
The MarketWatch 50 - Taylor SwiftThe MarketWatch 50 - Taylor Swift.
Weiterlesen »
SEC charges SolarWinds and company executive with fraud after cybersecurity breachBill Peters is a Los Angeles-based MarketWatch reporter who covers earnings.
Weiterlesen »
BP shares fall as oil major misses earnings expectations on gas tradingLouis Goss is a MarketWatch reporter based in London.
Weiterlesen »
JetBlue swings to a loss, stock falls in premarket tradesSteve Gelsi covers banking and cannabis as a Senior Reporter for MarketWatch.
Weiterlesen »
JetBlue stock loses altitude after facing 'staggering' weather delays — and warns of a wider-than-expected Q4 lossSteve Gelsi covers banking and cannabis as a Senior Reporter for MarketWatch.
Weiterlesen »
Miromatrix Medical stock soars after it agrees to be bought by United TherapeuticsSteve Gelsi covers banking and cannabis as a Senior Reporter for MarketWatch.
Weiterlesen »